ID: ALA4532101

Max Phase: Preclinical

Molecular Formula: C23H17N5S

Molecular Weight: 395.49

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  c1ccc(-c2cccc3nc(-c4cncs4)nc(NCc4ccccn4)c23)cc1

Standard InChI:  InChI=1S/C23H17N5S/c1-2-7-16(8-3-1)18-10-6-11-19-21(18)23(26-13-17-9-4-5-12-25-17)28-22(27-19)20-14-24-15-29-20/h1-12,14-15H,13H2,(H,26,27,28)

Standard InChI Key:  PWBWOYXKXHHDGJ-UHFFFAOYSA-N

Associated Targets(Human)

KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNA5 Tclin Voltage-gated potassium channel subunit Kv1.5 (1353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 395.49Molecular Weight (Monoisotopic): 395.1205AlogP: 5.43#Rotatable Bonds: 5
Polar Surface Area: 63.59Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.68CX LogP: 4.73CX LogD: 4.73
Aromatic Rings: 5Heavy Atoms: 29QED Weighted: 0.43Np Likeness Score: -1.39

References

1. Finlay HJ, Johnson JA, Lloyd JL, Jiang J, Neels J, Gunaga P, Banerjee A, Dhondi N, Chimalakonda A, Mandlekar S, Conder ML, Sale H, Xing D, Levesque P, Wexler RR..  (2016)  Discovery of 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a Potent I Kur Inhibitor.,  (9): [PMID:27660686] [10.1021/acsmedchemlett.6b00117]

Source